Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Röring, Melanie"'
Autor:
Nieskens, Tom T G, Peters, Janny G P, Schreurs, Marieke J, Smits, Niels, Woestenenk, Rob, Jansen, Katja, van der Made, Thom K, Röring, Melanie, Hilgendorf, Constanze, Wilmer, Martijn J, Masereeuw, Roos, Sub Experimental pharmacology, Pharmacology
Publikováno v:
The AAPS Journal
Aaps Journal, 18, 465-475
Aaps Journal, 18, 2, pp. 465-475
The AAPS journal, 18(2), 465. Springer New York LLC
Aaps Journal, 18, 465-475
Aaps Journal, 18, 2, pp. 465-475
The AAPS journal, 18(2), 465. Springer New York LLC
Drug-induced nephrotoxicity still hampers drug development, because current translation from in vitro or animal studies to human lacks high predictivity. Often, renal adverse effects are recognized only during clinical stages of drug development. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d6ebd434ee33e806398a0463b467a7
https://dspace.library.uu.nl/handle/1874/329958
https://dspace.library.uu.nl/handle/1874/329958
Autor:
Nieskens TT; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands., Peters JG; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands., Schreurs MJ; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands., Smits N; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands., Woestenenk R; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands., Jansen K; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands., van der Made TK; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands., Röring M; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands., Hilgendorf C; Innovative Medicines, Drug Safety and Metabolism, AstraZeneca R&D, Mölndal, Sweden., Wilmer MJ; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands. martijn.wilmer@radboudumc.nl.; Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboud University medical centre, P.O. box 9101, 6500 HB, Nijmegen, The Netherlands. martijn.wilmer@radboudumc.nl., Masereeuw R; Department of Pharmacology and Toxicology, Radboud Institute of Molecular Life Sciences, Radboud University medical center, Nijmegen, The Netherlands.; Division Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Publikováno v:
The AAPS journal [AAPS J] 2016 Mar; Vol. 18 (2), pp. 465-75. Date of Electronic Publication: 2016 Jan 28.
